Eli Lilly antibody treatment shows progress in those at high-risk
Eli Lilly’s antibody treatment reduces the risk of contracting COVID-19, according to the results of a new trial.
COVID antibody treatmentEli Lilly and company received authorization today to simplify how COVID antibody treatments are administered.
High risk individuals who test positive for COVID may be eligible for monoclonal antibody treatmentHigh risk individuals who test positive for COVID may be eligible for monoclonal antibody treatment
![COVID antibody treatment [Video]](https://video.newsserve.net/300/v/20210130/2101300145-COVID-antibody-treatment.jpg)
![High risk individuals who test positive for COVID may be eligible for monoclonal antibody treatment [Video]](https://video.newsserve.net/300/v/20210115/2101150011-High-risk-individuals-who-test-positive-for-COVID.jpg)
